Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 15/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27100392 | 0.85 | OGA (0.52) | OGALMNASMN1; SMN2GAAALDH1A1 | |
| SCHEMBL26374539 | 0.84 | OGA (0.52) | OGASMN1; SMN2OPRK1 | |
| SCHEMBL22079723 | 0.84 | OGA (0.64) | OGAOPRK1 | |
| SCHEMBL22078759 | 0.82 | OGA (0.47) | OGALMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL27100375 | 0.82 | OGA (0.54) | OGASMN1; SMN2 | |
| SCHEMBL21370037 | 0.81 | OGA (0.44) | OGALMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL21370045 | 0.80 | ALDH1A1 (0.47) | OGALMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL22078746 | 0.79 | LMNA (0.40) | OGALMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL22078769 | 0.78 | LMNA (0.40) | OGALMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL22079383 | 0.77 | SMN1; SMN2 (0.49) | OGALMNASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4327814-A2 | MORPHOLINYL, PIPERAZINYL, OXAZEPANYL AND DIAZEPANYL O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS | Biogen MA Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2020117961-A1 | MORPHOLINYL, PIPERAZINYL, OXAZEPANYL AND DIAZEPANYL O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS | BIOGEN MA INC. (US) | 2020-06-11 | — | — | WO | disclosed |